reference/23042882

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23042882

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	873
issn	1179-1926 0312-5963
issueIdentifier	7
pageRange	861-873
publicationName	Clinical Pharmacokinetics
startingPage	861
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_af2861cf9a67d88fdf0f3038d97be8d4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b879901c581f0dcadbb98f3419a8e08b
bibliographicCitation	Dickinson L, Amin J, Else L, Boffito M, Egan D, Owen A, Khoo S, Back D, Orrell C, Clarke A, Losso M, Phanuphak P, Carey D, Cooper DA, Emery S, Puls R. Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. Clinical Pharmacokinetics. 2015 Dec 29;55(7):861–73. doi: 10.1007/s40262-015-0360-5.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f8058eb7391635b0c9bf5df866b5b1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_020a794511c267f0417b407d02b79bd2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03cdd113e519d70ff8ed83e57614e5df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cce8056d2937f58de4cc82fa11c12f1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d51ab98ee574fab9b8332aa0b5534d69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6975e26399354a93305ebcb299659b1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24d52f1e6086e7658b163e9e2d663f9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_507150b5355a3519fac4d902660b753b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46c4333a0249038e150db43e1d077be6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6229f4916eb2fd0876c6eee1f6afbeb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfb13c62b8ce4497399530cdbde30c09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7022ae341a97bb452ec1f7f1c83038d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33ecbeaa2a85aa9b7c2bb99610bc9f4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa1743d1713942dea75100409831b7c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d2aeba98c2941e46c282a220ba4df1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8168a12eb685bbb600983309cc78ea9
date	2015-12-29^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/26715213 https://pubmed.ncbi.nlm.nih.gov/PMC4916189 https://doi.org/10.1007/s40262-015-0360-5
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3048 https://portal.issn.org/resource/ISSN/1179-1926 https://portal.issn.org/resource/ISSN/0312-5963
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study
discusses	http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0451043 http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M000747152 http://id.nlm.nih.gov/mesh/M000605888 http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0258297
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D048588Q000493 http://id.nlm.nih.gov/mesh/D019380Q000493 http://id.nlm.nih.gov/mesh/D048588Q000627 http://id.nlm.nih.gov/mesh/D015658Q000235 http://id.nlm.nih.gov/mesh/D019380Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019380Q000009 http://id.nlm.nih.gov/mesh/D019380Q000008 http://id.nlm.nih.gov/mesh/D048588Q000008 http://id.nlm.nih.gov/mesh/D000480 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010597 http://id.nlm.nih.gov/mesh/D000090702 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008657 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D003521 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000069480Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D012367Q000378 http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D048588Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_76ea5b13581f8d08294452a572707d6d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cfe12cc1ef206152ca6c36ba0a507b01 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aba769aba38697db62c2ecb774d4b9b6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d092985146af0387d160fa4baaed1ec

Showing number of triples: 1 to 87 of 87.